“Our process to evaluate potential corporate transactions, advised by Torreya a global investment bank specializing in life sciences, will continue in the fourth quarter given the importance of these near term milestones”
My guess is that Treagus is telling us the sale price is expected to go up with Orphan Drug Status and starting Ph3 for Retts..
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren approaching key milestones in Q4 2019
Ann: Neuren approaching key milestones in Q4 2019, page-8
-
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.68 |
Change
-0.100(0.48%) |
Mkt cap ! $2.643B |
Open | High | Low | Value | Volume |
$20.50 | $20.74 | $20.01 | $5.091M | 247.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 156 | $20.67 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.68 | 256 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 156 | 20.670 |
1 | 985 | 20.650 |
1 | 100 | 20.600 |
1 | 996 | 20.560 |
1 | 5982 | 20.550 |
Price($) | Vol. | No. |
---|---|---|
20.740 | 50 | 1 |
20.750 | 2085 | 3 |
20.790 | 1004 | 1 |
20.830 | 1004 | 1 |
20.870 | 1004 | 1 |
Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |